Klotho Neurosciences moves forward with manufacturing gene therapy to treat amyotrophic lateral sclerosis: New York Tuesday, July 1, 2025, 15:00 Hrs [IST] Klotho Neurosciences, In ...

We spoke with the developers and manufacturers of the CRISPR gene therapy used to treat KJ Muldoon’s rare genetic condition, ...

A new study highlights a historic step in personalized medicine, utilizing CRISPR gene-editing technology for a ...

Klotho Neurosciences, Inc. (NASDAQ: KLTO) today announced that it is moving forward with manufacturing and process development work in preparation for ...

US infants lacking Bifidobacterium in their gut microbiome face significant changes in microbial composition, metabolic ...

The Ferric Pyrophosphate Market presents strong growth opportunities driven by rising anemia cases, increasing demand for functional foods, and ...

Amid a challenging gene editing climate, partnerships between researchers, regulators, and industry remain crucial for ...

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

This valuable study presents a novel approach to enhance the therapeutic potential of mesenchymal stromal cells (MSCs) by genetically modifying their glycogen synthesis pathway, resulting in increased ...